US5530011AExpiredUtility

4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol

37
Assignee: JANSSEN PHARMACEUTICA NVPriority: Feb 14, 1992Filed: Mar 24, 1995Granted: Jun 25, 1996
Est. expiryFeb 14, 2012(expired)· nominal 20-yr term from priority
C07D 417/12
37
PatentIndex Score
1
Cited by
3
References
4
Claims

Abstract

A compound of formula <IMAGE> (I) <IMAGE> the racemic mixture, the (S)-form and the acid addition salts thereof, said compound having anti-stroke properties. Pharmaceutical compositions containing this compound as active ingredient and a method of preparing said compound and pharmaceutical compositions.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A method of treating strokes in patients suffering from the same which comprises administering to said patients an effective anti-stroke amount of a compound of the formula: ##STR13## the racemic mixture, the (S)-form, or a pharmaceutically acceptable acid addition salt thereof. 
     
     
       2. The method of claim 1 wherein the compound of Formula (I) is selected from the group consisting of (S)-4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol and its dihydrochloride salt. 
     
     
       3. A method of treating warm-blooded newborn patients suffering from postasphyxial brain damage which comprises administering to said patients an effective amount of a compound of the formula: ##STR14## the racemic mixture, the (S)-form, or a pharmaceutically acceptable acid addition salt thereof. 
     
     
       4. The method of claim 3 wherein the compound of Formula (I) is selected from the group consisting of (S)-4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol and its dihydrochloride salt.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.